BMO Capital analyst Joel Jackson raised the firm’s price target on Corteva (CTVA) to $86 from $74 and keeps an Outperform rating on the shares. The stock can continue to work as its current attractive multiples keep getting rolled forward on a strong growth profile, the analyst tells investors in a research note. BMO adds that Corteva is among the best-in-class among agricultural/fertilizer stocks for compelling multi-year double-digit EBITDA CAGR and margin expansion.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTVA:
- Corteva’s Strong Growth Potential and Financial Resilience Earns Buy Rating with Raised Target Price
- Corteva price target raised to $75 from $70 at Barclays
- Corteva price target raised to $82 from $79 at Wells Fargo
- Food, agriculture leaders warn of MAHA’s overreach, WSJ reports
- Corteva, Micropep partner on sustainable biocontrol solutions